Cargando…
Silencing RRM2 inhibits multiple myeloma by targeting the Wnt/β-catenin signaling pathway
Ribonucleotide reductase M2 (RRM2) is one of the two subunits that comprise ribonucleotide reductase (RR), the enzyme that catalyzes the conversion of ribonucleotide 5′-diphosphates into 2′-deoxyribonucleotides, which are required for DNA synthesis. RRM2 is a stress response factor important for the...
Autores principales: | Liu, Xia, Peng, Jiamin, Zhou, Yayun, Xie, Bei, Wang, Jianchao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691237/ https://www.ncbi.nlm.nih.gov/pubmed/31322175 http://dx.doi.org/10.3892/mmr.2019.10465 |
Ejemplares similares
-
Silencing c-Myc Enhances the Antitumor Activity of Bufalin by Suppressing the HIF-1α/SDF-1/CXCR4 Pathway in Pancreatic Cancer Cells
por: Liu, Xia, et al.
Publicado: (2020) -
RRM2 regulates osteogenesis of mouse embryo fibroblasts via the Wnt/β‑catenin signaling pathway
por: Cai, Haijun, et al.
Publicado: (2022) -
RRM2‑mediated Wnt/β‑catenin signaling pathway activation in lung adenocarcinoma: A potential prognostic biomarker
por: Jiang, Yongjie, et al.
Publicado: (2023) -
Role of Wnt/β-catenin pathway in inducing autophagy and apoptosis in multiple myeloma cells
por: Su, Nan, et al.
Publicado: (2016) -
Silencing of RIPK4 inhibits epithelial-mesenchymal transition by inactivating the Wnt/β-catenin signaling pathway in osteosarcoma
por: Yi, Zhigang, et al.
Publicado: (2020)